Deltagarlista

Här ser du deltagarlistan från seminariet Afternoon Tea – vi tar pulsen på Hagastaden, den 28 april.

På scen

  • Andreas Gretander, Phase2Phase Biopharma
  • Andreas Holmgren, AstraZeneca
  • Filippa Kull, Stockholm Science City
  • Helena Bladh, Takeda
  • Johan Weigelt, KI Science Park
  • Kajsa Liljegren, Stockholm Science City
  • Sara Gunnerås, KI Science Park

På plats

  • Adam Rogland Harutunian, SwedenBIO
  • Adelinn Kalman, CareDx
  • Amanda Antonsson, Nordic Healthcare Group (NHG)
  • Anders Granström, Dedicare Life Science
  • Anders Åker, Takeda
  • Andras Namslauer, Stockholm Science City
  • Andreas Fasth, Nefro Avillion Clinical Development / ITB-MED
  • Angie Anwar, Takeda Pharma AB
  • Anna Gällhagen, Carmeda AB
  • Anna Johansson, Region Stockholm/programkontor Norra Hagastaden
  • Anna Junell, LINK Medical AB
  • Anna Mironova-Hoch, Karolinska Universitetssjukhuset Region Sthlm
  • Annette Kraus, International Vaccine Institute (IVI)
  • Annette Roos, Syntagon AB
  • Bahram Ghandchi, Sina Care
  • Bo Pettersson, G&W Fondkommission
  • Carola Magnusson Boman, Link Arkitektur
  • Cecilia Lövdahl, Karolinska Institutet
  • Charlie Widberg, Invedo AB
  • Charlotta Dahlborg, Rouse / aera
  • Christina Jägare, Stockholm Science City
  • Cicilia Sjöholm, Takeda
  • Daniel Gurmu, RISE
  • Erhan Kayhan, Paratwin
  • Eva Bremberg, BRAVE Recruitment Sweden
  • Eva Pokkinen Forster, IQVIA
  • Ewa Borin, Ewa Borin Gallery
  • Fina Hossain, Karolinska Institutet
  • Frank Chen, MGM
  • Grace Tianjiao Fu, Eli Lilly and Company
  • Gunilla Hedlin, Karolinska Institutet
  • Hanna Sund, Oriola Advisory Services
  • Hans Gesteby Vindeland, Dovetail Public Affairs
  • Henry Werner, Takeda
  • Håkan Holmberg, paratwin
  • Jacopo Fontana, Karolinska Institutet
  • Jennifer Lees, IQVIA
  • Johan Dahlin, BMS
  • Johan Krohné, World Courier
  • Johan Lundberg, Vetenskapens Hus
  • John Skår, Karolinska Institutet
  • Joseffa Moritz, BMS
  • Jörg Bachmann, Scilifelab
  • Karl Alexanderson, White arkitekter
  • Karolina Wiktorson, Bergenstråhle & Partners
  • Kristina Martinell, Phase2Phase Biopharma Consulting AB
  • Lennart Pedersen, Pedersen & Partners AB
  • Lisa Bandholtz, Vinnova
  • Magdalena Tharaldsen, PeakSearch AB
  • Malin Wahlberg, Vasakronan
  • Maria Lundberg, LINK Medical AB
  • María Bueno Álvez, KTH
  • Matilda Bäckberg, Legado Bioresearch AB
  • Mattias Ståhl, Olink Proteomics
  • Michael Waltinger, Nordic Healthcare Group (NHG)
  • Mina Mousaeian, Stockholm Science City
  • Monica Renstig, Renstig consulting group AB
  • Nabiha Basmaji Skoglund, Karolinska universitetssjukhuset
  • Nicolina Rosvall, Nordic Healthcare Group Sverige
  • Oscar Jungholm, Jungholm Labs AB
  • Peo Karlsson, LINK Arkitektur
  • Per Malmquist, Analys & statistik
  • Pernilla Boström, Stiftelsen Flemingsberg Science
  • Richard Cowburn, Karolinska Institutet
  • Sebina Cehic Husic, Karolinska Universitetssjukhuset
  • Setareh Arya, ImmunoIVD
  • Sheila Forsman, SF solutions AB
  • Sima Zangiabadi, Region Stockholm
  • Sofia Ortlepp, Diapharm GmbH & Co KG
  • Srinivasa Rao Nagubothu, Syntrophy AI Nordic AB
  • Stefan Tovesson, Karolinska Universitetssjukhuset
  • Svante Almkvist, Phase2Phase Biopharma
  • Therese Sundell, Paek Search
  • Ulla Tunkara, Karolinska Institutet
  • Ulrich Lauridsen, aera
  • Vijay Sai Josyula, Uppsala University
  • Yatong Wen, Karolinska Institutet
  • Ylva Skoglösa, aera AB
  • Åsa Benteke Werner, Tysk-Svenska Handelskammaren